• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有铁螯合能力的新型β-二酮衍生物的合成与表征

Synthesis and characterization of new beta-diketo derivatives with iron chelating ability.

作者信息

Benassi Rois, Ferrari Erika, Grandi Romano, Lazzari Sandra, Saladini Monica

机构信息

Department of Chemistry, University of Modena and Reggio Emilia, Via Campi 183, 41100 Modena, Italy.

出版信息

J Inorg Biochem. 2007 Feb;101(2):203-13. doi: 10.1016/j.jinorgbio.2006.09.020. Epub 2006 Sep 29.

DOI:10.1016/j.jinorgbio.2006.09.020
PMID:17097145
Abstract

Here we report the synthesis, the characterization and a theoretical study on new glycosylated phenyl substituted beta-diketones; two classes of compounds are obtained according to the condensation reaction: central and side derivatives. Their iron(III) chelating ability is tested by means of UV-visible (UV-vis), potentiometric and NMR techniques. The conformation of central derivatives does not allow any metal chelation, while side derivatives bind iron(III) through the beta-dioxo moiety. The glycosyl moiety does not interact with metal ion but it helps to stabilize metal/ligand (1/3) complexes by means of hydrophylic interactions. The pK(a) of the ligands and the stability constants of their Fe(III) complexes are evaluated by means of UV-vis spectroscopy and potentiometry. A comparison with other iron-chelating agents, on the basis of lipophilicity and the pFe(III), is finally reported.

摘要

在此,我们报告了新型糖基化苯基取代β-二酮的合成、表征及理论研究;根据缩合反应得到了两类化合物:中心衍生物和侧链衍生物。通过紫外可见(UV-vis)、电位滴定和核磁共振(NMR)技术测试了它们与铁(III)的螯合能力。中心衍生物的构象不允许任何金属螯合,而侧链衍生物通过β-二氧代部分与铁(III)结合。糖基部分不与金属离子相互作用,但通过亲水相互作用有助于稳定金属/配体(1/3)配合物。通过紫外可见光谱和电位滴定法评估了配体的pK(a)及其铁(III)配合物的稳定常数。最后报告了基于亲脂性和pFe(III)与其他铁螯合剂的比较。

相似文献

1
Synthesis and characterization of new beta-diketo derivatives with iron chelating ability.具有铁螯合能力的新型β-二酮衍生物的合成与表征
J Inorg Biochem. 2007 Feb;101(2):203-13. doi: 10.1016/j.jinorgbio.2006.09.020. Epub 2006 Sep 29.
2
Synthesis and characterization of glucosyl-curcuminoids as Fe3+ suppliers in the treatment of iron deficiency.作为铁缺乏症治疗中铁离子供应体的糖基化姜黄素类化合物的合成与表征
Biometals. 2009 Oct;22(5):701-10. doi: 10.1007/s10534-009-9213-8. Epub 2009 Feb 11.
3
Iron(III) complexing ability of carbohydrate derivatives.碳水化合物衍生物的铁(III)络合能力。
J Inorg Biochem. 2004 Jun;98(6):1002-8. doi: 10.1016/j.jinorgbio.2004.02.017.
4
Novel trihydroxamate-containing peptides: design, synthesis, and metal coordination.含新型三异羟肟酸的肽:设计、合成与金属配位
Biopolymers. 2006;84(5):472-89. doi: 10.1002/bip.20532.
5
Evaluation of 2-methyl-3-hydroxy-4-pyridinecarboxylic acid as a possible chelating agent for iron and aluminium.评估2-甲基-3-羟基-4-吡啶羧酸作为铁和铝的潜在螯合剂的性能。
Dalton Trans. 2008 Apr 7(13):1689-97. doi: 10.1039/b717269a. Epub 2008 Feb 14.
6
Unprecedented oxidation of a biologically active aroylhydrazone chelator catalysed by iron(III): serendipitous identification of diacylhydrazine ligands with high iron chelation efficacy.铁(III)催化的具有生物活性的芳酰腙螯合剂的前所未有的氧化反应:意外发现具有高铁螯合功效的二酰肼配体。
J Biol Inorg Chem. 2001 Oct;6(8):801-9. doi: 10.1007/s007750100258.
7
Synthesis, chemical and biological studies on new Fe(3+)-glycosilated beta-diketo complexes for the treatment of iron deficiency.用于治疗缺铁的新型铁(Ⅲ)-糖基化β-二酮配合物的合成、化学及生物学研究
Eur J Med Chem. 2008 Nov;43(11):2549-56. doi: 10.1016/j.ejmech.2008.02.045. Epub 2008 Mar 14.
8
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III).曲酸衍生物作为铁(III)和铝(III)的强螯合剂。
Dalton Trans. 2011 Jun 14;40(22):5984-98. doi: 10.1039/c1dt00005e. Epub 2011 May 9.
9
Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase.α-N-杂环硫代半卡巴腙的镓(III)和铁(III)配合物:合成、表征、细胞毒性以及与核糖核苷酸还原酶的相互作用
J Med Chem. 2007 Mar 22;50(6):1254-65. doi: 10.1021/jm0612618. Epub 2007 Feb 22.
10
Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.用于治疗铁过载疾病的新型铁螯合剂的构效关系:甲基吡嗪基酮异烟酰腙系列
J Med Chem. 2008 Jan 24;51(2):331-44. doi: 10.1021/jm7012562. Epub 2007 Dec 27.

引用本文的文献

1
study of the potential of curcumin and its derivatives for increasing wild-type p53 expression and improving the function of p53 mutant R273H.姜黄素及其衍生物提高野生型p53表达和改善p53突变体R273H功能潜力的研究。
Vet World. 2025 Mar;18(3):715-730. doi: 10.14202/vetworld.2025.715-730. Epub 2025 Mar 31.
2
The effects of curcumin on hepatic T2*MRI and liver enzymes in patients with β-thalassemia major: a double-blind randomized controlled clinical trial.姜黄素对重型β地中海贫血患者肝脏T2*磁共振成像及肝酶的影响:一项双盲随机对照临床试验。
Front Pharmacol. 2023 Dec 18;14:1284326. doi: 10.3389/fphar.2023.1284326. eCollection 2023.
3
Development of Stable Amino-Pyrimidine-Curcumin Analogs: Synthesis, Equilibria in Solution, and Potential Anti-Proliferative Activity.
稳定的氨基嘧啶-姜黄素类似物的开发:合成、溶液中的平衡和潜在的抗增殖活性。
Int J Mol Sci. 2023 Sep 11;24(18):13963. doi: 10.3390/ijms241813963.
4
Curcumin-Based β-Diketo Ligands for Ga: Thermodynamic Investigation of Potential Metal-Based Drugs.用于镓的基于姜黄素的β-二酮配体:潜在金属基药物的热力学研究
Pharmaceuticals (Basel). 2022 Jul 12;15(7):854. doi: 10.3390/ph15070854.
5
A Review of Curcumin and Its Derivatives as Anticancer Agents.姜黄素及其衍生物作为抗癌剂的研究进展。
Int J Mol Sci. 2019 Feb 27;20(5):1033. doi: 10.3390/ijms20051033.
6
Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies.基于 DOTA-姜黄素的潜在镓-68 标记放射性示踪剂用于结直肠癌细胞的研制:从合成到体内研究。
Molecules. 2019 Feb 12;24(3):644. doi: 10.3390/molecules24030644.
7
Nanotechnology-applied curcumin for different diseases therapy.应用纳米技术的姜黄素用于不同疾病的治疗。
Biomed Res Int. 2014;2014:394264. doi: 10.1155/2014/394264. Epub 2014 Jun 5.
8
4-Formyl-phenyl 2,3,4,6-tetra-O-acetyl-β-d-galactopyran-oside.4-甲酰基苯基 2,3,4,6-四-O-乙酰基-β-D-吡喃半乳糖苷
Acta Crystallogr Sect E Struct Rep Online. 2011 Apr 1;67(Pt 4):o826. doi: 10.1107/S1600536811008257. Epub 2011 Mar 9.